€ €
M. Yıldırım, Y. Durust / Tetrahedron 67 (2011) 3209e3215
3214
1:4). IR (KBr):
n
¼3036, 2922 (CeH), 2852, 1597 (C]N), 1500, 1390,
(m/z, %)¼347 (100) [MH]þ, 348 (25) [MH]þ. HRMS calculated for
1325, 1124, 815, 748 cmꢀ1. TOF-MS EIþ: (m/z, %)¼292 (30) [M]þ, 272
(15), 235 (100), 77 (20). HRMS calculated for C19H20N2O3 292.1576;
found 292.1578.
C19H18N2OF3 347.1371; found 347.1371.
4.2.6. (R)-3-(4-Bromophenyl)-1-(4-chlorophenyl)-5-((R)-2-methyl-
oxiran-2-yl)-4,5-dihydro-1H-pyrazole (6f) and (R)-3-(4-bromo-
phenyl)-1-(4-chlorophenyl)-5-((S)-2-methyloxiran-2-yl)-4,5-dihy-
dro-1H-pyrazole (7f). Two inseparable diastereomers. Compounds
6fe7f: White needles (108 mg, 95%). Melting range: 126e128 ꢂC. Rf:
4.2.3. (R)-5-((R)-2-Methyloxiran-2-yl)-3-(4-nitrophenyl)-1-phenyl-
4,5-dihydro-1H-pyrazole (6c) and (R)-5-((S)-2-methyloxiran-2-yl)
-3-(4-nitrophenyl)-1-phenyl-4,5-dihydro-1H-pyrazole (7c). Two sep-
arated diastereomers. Compound 6c: Light orange needles (from
diisopropylphenylethereacetone) (30 mg, 20%). Mp 155e157 ꢂC. Rf:
0.40e0.30 (ethyl acetateen-hexane; 1:2). IR (KBr):
n
¼3049, 2922
(CeH), 2850, 1597 (C]N), 1490, 1386, 1093, 1006, 821 cmꢀ1. TOF-
MS APþ: (m/z, %)¼391 (80) [M]þ, 393 (100) [M]þþ2. HRMS calcu-
lated for C18H17N2OClBr 391.0213; found 391.0216.
0.75 (ethyl acetateen-hexane; 1:2). IR (KBr):
n
¼3047, 2924 (CeH),
2850, 1593 (C]N), 1552, 1500, 1340, 1107, 846, 752 cmꢀ1. TOF-MS
EIþ: (m/z, %)¼323 (35) [M]þ, 266 (90), 235 (95), 83 (100). HRMS
calculated for C18H17N3O3 323.1270; found 323.1276. Selected
4.2.7. (R)-1-(4-Chlorophenyl)-5-((R)-2-methyloxiran-2-yl)-3-(4-ni-
trophenyl)-4,5-dihydro-1H-pyrazole (6g) and (R)-1-(4-chloro-
phenyl)-5-((S)-2-methyloxiran-2-yl)-3-(4-nitrophenyl)-4,5-dihydro-
1H-pyrazole (7g). Two separated diastereomers. Compound 6g: Light
orange needles (40 mg, 24%). Mp 195e197 ꢂC. Rf: 0.60 (ethyl
crystallographic data: C18H17N3O3 F(000)¼680, Mr¼323.35,
Dx¼1.392 Mg mꢀ3. Monoclinic, P21/c Cu K
a
radiation,
l
¼1.54178 A.
ꢀ
Hall symbol: ꢀP 2 ybc. Cellꢂparameters from 3237 reflections
¼0.79 mmꢀ1
,
ꢀ
ꢀ
a¼17.0933 (9) A,
q
¼5.1e67.6 , b¼9.9259 (5) A,
m
c¼9.3363 (4) A, T¼90 K,
b
¼103.091 (3)ꢂ. Plate, Orange V¼1542.89
acetateen-hexane; 1:2). IR (KBr):
n
¼3109, 3039, 2912 (CeH), 2848,
ꢀ
3
(13) A , 0.24ꢁ0.21ꢁ0.05 mm, Z¼4. Data collection Bruker APEX-II
1593 (C]N), 1496, 1342, 1109, 819, 752 cmꢀ1. TOF-MS EIþ: (m/z,
%)¼357 (25) [M]þ, 327 (30), 300 (60), 269 (100). HRMS calculated
for C18H16N3O3Cl 357.0880; found 357.0876.
ꢀ
CCD diffractometer 8539 independent reflections. Radiation
source: fine-focus sealed tube 6947 reflections with I>2s(I)
graphite Rint¼0.0000
4
and
u
scans qmax¼69.3ꢂ, qmin¼5.1ꢂ. Ab-
Compound 7g: Orange-red needles (60 mg, 35%). Mp
sorption correction: Multi-scan SADABS (Sheldrick, 2002)
h¼ꢀ20/20Tmin¼0.832, Tmax¼0.961, k¼ꢀ11/118,539 measured
reflections l¼ꢀ8/10.
189e191 ꢂC. Rf: 0.45 (ethyl acetateen-hexane; 1:2). IR (KBr):
n
¼3064, 2924 (CeH), 2856,1593 (C]N),1491,1338,1323,1141,1097,
848, 821, 748 cmꢀ1. TOF-MS EIþ: (m/z, %)¼357 (25) [M]þ, 327 (40),
300 (60), 270 (100). HRMS calculated for C18H16N3O3Cl 357.0880;
found 357.0877.
Compound 7c: Dark orange needles (from diisopropylphenyle-
thereacetone) (25 mg, 20%). Mp 152e154 ꢂC. Rf: 0.62 (ethyl
acetateen-hexane; 1:2). IR (KBr):
n
¼3059, 2926 (CeH), 2854, 1593
(C]N),1552,1502,1340,1107, 846, 752 cmꢀ1. TOF-MS EIþ: (m/z, %)¼
323 (5) [M]þ, 289 (20), 273 (40), 235 (100), 83 (100). HRMS calcu-
lated for C18H17N3O3 323.1270; found 323.1269. Selected crystallo-
4.2.8. 4-((R)-5-((R)-2-Methyloxiran-2-yl)-3-p-tolyl-4,5-dihydro-1H-
pyrazol-1-yl) benzonitrile (6h) and 4-((R)-5-((S)-2-methyloxiran-2-
yl)-3-p-tolyl-4,5-dihydro-1H-pyrazol-1-yl)benzonitrile (7h). Two
inseparable diastereomers. Brown powder (75 mg, 65%). Melting
range: 137e145 ꢂC. Rf: 0.22e0.11 (ethyl acetateen-hexane; 1:2). IR
graphic data: C18H17N3O3 Z¼2, Mr¼323.35, F(000)¼340. Triclinic, P1
Dx¼1.391 Mg mꢀ3. Hall symbol: ꢀP 1 Cu K
a
radiation,
l
¼1.54178 A,
ꢀ
ꢀ
a¼6.2053 (7) A. Cꢂell parameters from 891 reflections b¼10.8579
(KBr):
n¼3049, 2922 (CeH), 2860, 2214 (C^N), 1605 (C]N), 1510,
ꢀ
ꢀ
(12) A,
q
¼3.7e56.9 , c¼11.8305 (14) A,
m
¼0.79 mmꢀ1
, a
g
¼98.431 (9)ꢂ,
1398, 1332, 1174, 827 cmꢀ1. TOF-MS APþ: (m/z, %)¼318 (100) [M]þ,
359 (30) [M]þþK. HRMS calculated for C20H20N3O 318.1606; found
318.1620.
T¼90 K,
b
¼91.549 (9)ꢂ. Fragment, Orange
¼101.223 (9)ꢂ
3
ꢀ
0.13ꢁ0.10ꢁ0.04 mm, V¼772.14 (15) A . Data collection Bruker APEX-
II CCD diffractometer 2186 independent reflections. Radiation
source: fine-focus sealed tube 1086 reflections with I>2s(I) graphite
5. Supplementary data
Rint¼0.118
4
and
u
scans qmax¼59.1ꢂ, qmin¼3.7ꢂ. Absorption correc-
tion: Multi-scan SADABS (Sheldrick, 2002) h¼ꢀ5/6 Tmin¼0.904,
Tmax¼0.969, k¼ꢀ9/126,710 measured reflections l¼ꢀ12/13.
Full crystallographic data for 7c and 6c have been deposited
with the CCDC reference numbers 798327, 797328, respectively,
4.2.4. (R)-3-(4-Methoxyphenyl)-5-((R)-2-methyloxiran-2-yl)-1-phe-
nyl-4,5-dihydro-1H-pyrazole (6d) and (R)-3-(4-methoxyphenyl)-5-
((S)-2-methyloxiran-2-yl)-1-phenyl-4,5-dihydro-1H-pyrazole (7d).
As a mixture of two inseparable diastereomers. Compounds6de7d:
Brown oil (75 mg, 65%). Rf: 0.75e0.65 (ethyl acetateen-hexane;
Acknowledgements
_
Abant Izzet Baysal University, Directorate of Research Projects
1:2). IR (KBr):
n
¼3049, 2931 (CeH), 2837, 1597 (C]N), 1500, 1390,
Commission (BAP grant no. 2007.03.03.260) and TUBITAK (Turkish
Scientific and Technological Research Council) (grant no. 106T645)
are gratefully acknowledged for financial support.
The authors also thank to Professor D.W. Knight (School of
Chemistry, Cardiff University, U.K.) for HRMS measurements and
Dr. F.R. Fronczek (Department of Chemistry, Louisiana State Uni-
versity, U.S.A.) for X-Ray data.
1251, 1172, 833, 748 cmꢀ1. TOF-MS EIþ: (m/z, %)¼308 (55) [M]þ, 251
(100), 235 (80), 207 (50). HRMS calculated for C19H20N2O2
308.1525; found 308.1522.
4.2.5. (R)-5-((R)-2-Methyloxiran-2-yl)-1-phenyl-3-(4-(tri-
fluoromethyl)phenyl)-4,5-dihydro-1H-pyrazole (6e) and (R)-5-((S)
-2-methyloxiran-2-yl)-1-phenyl-3-(4-(trifluoromethyl)phenyl)-4,5-
dihydro-1H-pyrazole (7e). Two separated diastereomers. Compound
6e: Light green powder (50 mg, 44%). Mp 118e120 ꢂC. Rf: 0.44
References and notes
1. Huisgen, R. Angew. Chem. 1963, 75, 604e637.
2. Huisgen, R.; Grashey, R.; Knupfer, H.; Kunz, R.; Siedel, M. Chem. Ber. 1964, 97,
1085e1095.
3. Fliege, W.; Huisgen, R.; Clovis, J. S.; Knupfer, H. Chem. Ber. 1983, 116,
3039e3061.
4. Komatsu, M.; Yoshida, Y.; Uesaka, M.; Ohshiro, Y.; Agawa, T. J. Org. Chem. 1984,
49, 1300e1302.
(ethyl acetateen-hexane; 1:4). IR (KBr):
n
¼3055, 2928 (CeH), 2848,
1599 (C]N), 1498, 1325, 1122, 1066, 840, 748 cmꢀ1. TOF-MS APþ:
(m/z, %)¼347 (100) [MH]þ, 348 (25) [MH]þ, 318 (15), 289 (15).
HRMS calculated for C19H18N2OF3 347.1371; found 347.1375.
Compound 7e: Light green oil (45 mg, 40%). Rf: 0.33 (ethyl
acetateen-hexane; 1:4). IR (KBr):
n
¼3061, 2928 (CeH), 2854, 1593
5. Luheshi, A. B. N.; Smalley, R. K.; Kennewell, P. D.; Westwood, R. Tetrahedron Lett.
1990, 31, 127e130.
(C]N), 1599, 1500, 1325, 1124, 1066, 842, 750 cmꢀ1. TOF-MS APþ: